Literature DB >> 3279142

Clinical evaluation of hyperthermia equipment: the University of Arizona Institutional Report for the NCI Hyperthermia Equipment Evaluation Contract.

D S Shimm1, T C Cetas, J R Oleson, J R Cassady, D A Sim.   

Abstract

Two-hundred and fifteen independent sites in 203 patients were treated with hyperthermia at the University of Arizona from 10/81 through 3/86 under the auspices of this contract. In the head and neck, a site dominated by superficial tumors, air-coupled and water-coupled microwave applicators yielded the best results. Similarly in the thorax, also dominated by superficial tumors, water-coupled microwave applicators were best. In the abdomen and pelvis, sites dominated by deep tumors, only interstitial radiofrequency (RF) heating, an invasive technique useful only in selected cases, was capable of consistently producing therapeutic temperatures. Toxicity appeared to be site-related, and treatment discomfort was especially common in abdominal and pelvic sites. In conclusion, while superficial sites were readily heated using propagative electromagnetic devices, these devices were ineffective and poorly tolerated at deeper sites. Effective deep hyperthermia was best produced with interstitial techniques, and further development of these techniques using RF electrodes, implantable microwave antennas and thermoregulating ferromagnetic seeds, as well as scanned, focussed-ultrasound techniques, holds promise for effective heating of deep visceral sites.

Entities:  

Mesh:

Year:  1988        PMID: 3279142     DOI: 10.3109/02656738809032048

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  2 in total

1.  Radio-frequency ring applicator: energy distributions measured in the CDRH phantom.

Authors:  G C van Rhoon; P Raskmark; S N Hornsleth; P M van den Berg
Journal:  Med Biol Eng Comput       Date:  1994-11       Impact factor: 2.602

2.  Clinical evaluation of 430 MHz microwave hyperthermia system with lens applicator for cancer therapy.

Authors:  M Hiraoka; Y Nishimura; S Masunaga; M Koishi; M Mitsumori; Y P Li; Y Nagata; K Akuta; M Takahashi; M Abe
Journal:  Med Biol Eng Comput       Date:  1995-01       Impact factor: 2.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.